Literature DB >> 18774540

ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease.

Adriano Paula Sabino1, Marinez De Oliveira Sousa, Luciana Moreira Lima, Daniel Dias Ribeiro, Luci Maria Sant'Ana Dusse, Maria Das Graças Carvalho, Ana Paula Fernandes.   

Abstract

Although smoking and hypertension are classic risk factors for atherothrombotic diseases, the relationship of dyslipidemia and vascular diseases, other than myocardial infarction, is less clearly established, especially in young subjects. In the current study, a detailed analysis of the lipid and apolipoprotein profiles was conducted in young patients of ischemic cerebral stroke (IS) and peripheral arterial disease (PAD). Plasma levels of C-reactive protein (hs-CRP), total cholesterol (TC), high-density lipoprotein cholesterol (HDLc), low-density lipoprotein cholesterol (LDLc), triglycerides (TG), and apolipoproteins A-I (ApoA-I) and apolipoproteins B (ApoB), which include the ApoB/ApoA-I ratio, were analyzed in a group of 81 patients who presented with IS (n = 46) or PAD (n = 35) as well as in 167 control subjects. Significant differences were observed for hs-CRP, TC, HDLc, LDLc, TG, ApoA-I, and ApoB levels, as well as for the ApoB/ApoA-I ratio, between the control and the IS or PAD groups. However, after adjustment for sex, age, smoking, hypertension, hs-CRP, and dyslipidemia (LDLc, TC, HDLc, TG, ApoA, ApoB, and ApoB/ApoA-I ratio), hs-CRP, ApoB, and the ApoB/ApoA-I ratio were independently associated with increased risks of IS or PAD. Increased ApoB/ApoA-I ratio and hs-CRP levels are independently associated with occurrence of IS and PAD in young patients and are significant markers of alterations on lipid and apolipoproteic profiles and inflammatory responses, respectively, in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774540     DOI: 10.1016/j.trsl.2008.06.005

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  10 in total

1.  A study of serum apolipoprotein A1, apolipoprotein B and lipid profile in stroke.

Authors:  Shilpasree As; Savitri Sahukar; Jayaprakash Murthy; Kiran Kumar
Journal:  J Clin Diagn Res       Date:  2013-07-01

2.  Evaluation of Lipid Profile and Apolipoproteins in Essential Hypertensive Patients.

Authors:  Parsuram Nayak; Suchismita Panda; Pravat Kumar Thatoi; Roma Rattan; Srikrushna Mohapatra; Pramila Kumari Mishra
Journal:  J Clin Diagn Res       Date:  2016-10-01

3.  Apolipoprotein B: novel indicator of elevated intraocular pressure.

Authors:  J H Son; Y K Chung; J S Son
Journal:  Eye (Lond)       Date:  2015-03-20       Impact factor: 3.775

4.  Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and PAI-1 plasma levels in young patients with ischemic stroke.

Authors:  Adriano de Paula Sabino; Daniel Dias Ribeiro; Caroline Pereira Domingueti; Mariana Silva Dos Santos; Telma Gadelha; Luci Maria Santana Dusse; Maria das Graças Carvalho; Ana Paula Fernandes
Journal:  Mol Biol Rep       Date:  2011-03-04       Impact factor: 2.316

5.  Uric acid blood levels and relationship with the components of metabolic syndrome in hypertensive patients.

Authors:  M V Papavasileiou; A G Karamanou; P Kalogeropoulos; G Moustakas; S Patsianis; A Pittaras
Journal:  J Hum Hypertens       Date:  2015-07-02       Impact factor: 3.012

Review 6.  Apolipoprotein A1, B levels, and their ratio and the risk of a first stroke: a meta-analysis and case-control study.

Authors:  Hongli Dong; Wei Chen; Xiangyu Wang; Fuhua Pi; Yubin Wu; Shaojie Pang; Yuqing Xie; Fangfang Xia; Qingying Zhang
Journal:  Metab Brain Dis       Date:  2015-09-12       Impact factor: 3.584

7.  Additive interaction between potentially modifiable risk factors and ethnicity among individuals in the Han, Tujia and Miao populations with first-ever ischaemic stroke.

Authors:  Na Zhang; Xinrui Wu; Mengyuan Tian; Xiaolei Wang; Jian Ding; Yong Tian; Chengcai Liang; Zhi Zeng; Hua Xiang; Hongzhuan Tan
Journal:  BMC Public Health       Date:  2021-06-03       Impact factor: 3.295

8.  The Correlation between Serum ApoA1 and B and Coronary Artery Disease as Well as Its Severity.

Authors:  Navid Reza Mashayekhi; Saeid Sadrnia; Ali Chehrei; Javad Javaheri
Journal:  Int Cardiovasc Res J       Date:  2014-01-01

9.  Identification of dyslipidemia as a risk factor for sudden sensorineural hearing loss: A multicenter case-control study.

Authors:  Xiaoqing Li; Binghua Chen; Xingxing Zhou; Fan Ye; Yumin Wang; Wangqiang Hu
Journal:  J Clin Lab Anal       Date:  2021-10-21       Impact factor: 2.352

10.  The expression of apolipoproteina1 and its correlation with infiltration of urologic neoplasm.

Authors:  Huihui Hu; Bei Gong; Man Zhang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.